Advertisement
CRCA vs SPXL
Which ETF would AI Choose? ProShares Ultra CRCL (CRCA) vs. Direxion Daily S&P 500 Bull 3X Shares (SPXL)
Key Takeaways
- ProShares Ultra CRCL (CRCA) delivers 2x daily exposure to a single stock, Circle Internet Group, Inc. (CRCL), a fintech leader in USD-backed stablecoins, while Direxion Daily S&P 500 Bull 3X Shares (SPXL) provides 3x daily exposure to the broad S&P 500 Index.
- CRCA is a concentrated, thematic leveraged product with high volatility tied to one company’s performance; SPXL offers diversified large-cap U.S. equity exposure across approximately 500 holdings.
- Expense ratios stand at 0.95% for CRCA and 0.84% for SPXL, reflecting the structural costs of leveraged strategies.
- Both ETFs employ daily reset leverage, making them suitable primarily for short-term tactical use rather than long-term buy-and-hold strategies due to compounding effects.
- CRCA targets the emerging stablecoin and blockchain infrastructure theme; SPXL captures broad market beta amplified for bullish short-term views on U.S. large-cap equities.
- Liquidity profiles differ markedly, with SPXL maintaining significantly higher average daily volume and assets under management compared to the newer CRCA fund.
Introduction
Investors seeking amplified equity exposure now face a choice between two distinct leveraged exchange-traded funds (ETFs). ProShares Ultra CRCL (CRCA) and Direxion Daily S&P 500 Bull 3X Shares (SPXL) do not compete directly for the same mandate. Instead, they represent alternative strategies: one concentrated on a single fintech name and the other providing broad-market leverage. This comparison highlights structural differences that matter for investors evaluating thematic versus diversified leveraged positioning in the current market environment.
ProShares Ultra CRCL (CRCA) Overview
ProShares Ultra CRCL (CRCA) seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of Class A common shares of Circle Internet Group, Inc. (CRCL). The fund is non-diversified and primarily provides leveraged exposure to a single holding. It launched in August 2025 and carries a net expense ratio of 0.95%. As a daily-reset leveraged product, CRCA resets exposure each trading day, which can lead to significant divergence from 2x results over longer periods. The strategy focuses on the stablecoin and blockchain infrastructure sector through its underlying company.
Direxion Daily S&P 500 Bull 3X Shares (SPXL) Overview
Direxion Daily S&P 500 Bull 3X Shares (SPXL) seeks daily investment results, before fees and expenses, of 300% (3x) of the performance of the S&P 500 Index. The fund invests in financial instruments such as swaps, securities, and ETFs to achieve its leveraged objective. It holds exposure across roughly 500 large-cap U.S. companies, with top holdings typically including major technology and growth names. SPXL maintains a net expense ratio of 0.84% and has operated since 2008. Like other daily-reset leveraged ETFs, its structure requires frequent rebalancing to maintain target leverage.
Industry and Thematic Backdrop
The comparison occurs against a backdrop of evolving fintech innovation alongside broad equity market dynamics. Stablecoin adoption and blockchain infrastructure developments continue to drive interest in specialized financial technology names. Meanwhile, the S&P 500 remains influenced by large-cap technology sector performance, interest rate expectations, and overall economic growth. Leveraged products in both areas attract short-term capital seeking amplified exposure during periods of sector momentum or market rotation.
Performance and Positioning Comparison
In recent market cycles, the concentrated nature of ProShares Ultra CRCL (CRCA) has produced higher volatility tied to movements in its single underlying holding. Direxion Daily S&P 500 Bull 3X Shares (SPXL) has reflected broader large-cap equity trends amplified by 3x daily leverage. Relative positioning favors SPXL for investors seeking diversified U.S. equity beta and CRCA for those targeting specific fintech or stablecoin-related momentum. Both funds exhibit the typical characteristics of daily-reset leveraged vehicles, where holding periods beyond one day can materially alter realized returns relative to the stated multiple.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Investors seeking data-driven insights into leveraged or thematic ETFs may find the tool useful for refining their research process.
Tickeron AI Verdict
Based on observable factors including broader diversification, established liquidity profile, lower expense ratio, and consistent sector momentum across large-cap equities, Tickeron’s AI would currently assign a higher probability of structural suitability to Direxion Daily S&P 500 Bull 3X Shares (SPXL) for investors pursuing short-term leveraged market exposure. ProShares Ultra CRCL (CRCA) offers targeted thematic leverage but carries elevated single-name concentration risk.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRCA is a Hold and SPXL is a Hold.
Momentum Indicator for CRCA turns negative, indicating new downward trend
CRCA saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator turned negative. In 24 of the 24 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for CRCA turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 8 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
The 10-day moving average for CRCA crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CRCA entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRCA advanced for three days, in 50 of 57 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
CRCA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
SPXL's RSI Oscillator ascends from oversold territory
The RSI Oscillator for SPXL moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 28 of the 31 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +5.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPXL advanced for three days, in 321 of 351 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
SPXL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SPXL as a result. In 64 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
The Moving Average Convergence Divergence Histogram (MACD) for SPXL turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In 50 of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
SPXL moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SPXL crossed bearishly below the 50-day moving average on October 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPXL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for SPXL entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
| CRCA | SPXL | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 90% |
| Stochastic ODDS (%) | 3 days ago 87% | 3 days ago 90% |
| Momentum ODDS (%) | 3 days ago 90% | 3 days ago 86% |
| MACD ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 88% |
| TrendMonth ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Advances ODDS (%) | 5 days ago 88% | 5 days ago 90% |
| Declines ODDS (%) | 3 days ago 90% | 7 days ago 88% |
| BollingerBands ODDS (%) | 3 days ago 89% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 90% |
Advertisement